Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Nunes

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Journal of Cancer Research and Clinical Oncology|May 16, 2020
Advanced renal cell carcinoma (RCC) management: an expert panel recommendation from the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG)Andrey Soares, Fernando Sabino Marques Monteiro, Fernando Cotait Maluf, et al.
Therapeutic Advances in Urology|September 17, 2019
Renal cell cancer treatment: an expert panel recommendation from the Latin American cooperative group-genitourinary and the Latin American renal cancer group: focus on surgeryStênio de Cássio Zequi, Walter Henriques da Costa, Fernando Korkes, et al.
Clinical Genitourinary Cancer|August 24, 2024
The Impact of Fibroblast Growth Factor Receptor Alterations in Clinical Outcomes of Patients With Advanced Urothelial Carcinoma: Real-World Data From a Latin American PopulationVinicius Carrera Souza, Fernando Sabino Marques Monteiro, Fernando Cotait Maluf, et al.
Medrxiv : the Preprint Server for Health Sciences|August 20, 2025
Modelling Acral Melanoma in Admixed Brazilians Uncovers Genomic Drivers and Targetable PathwaysAnnie Cristhine Moraes Sousa-Squiavinato, Sara Santos Bernardes, Flávia C Aguiar, et al.
Lung Cancer Management|June 6, 2025
Lung cancer screening in limited resource regions: the 3rd Brazilian Early Lung Cancer Trial (BRELT3/mobile ProPulmão)Ricardo Sales Dos Santos, Ricardo G Figueiredo, Juliana P Franceschini, et al.
Journal of Cancer Research and Clinical Oncology|April 9, 2024
Advanced renal cell carcinoma management: the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG) consensus updateAndrey Soares, Fernando Sabino Marques Monteiro, Karine Martins da Trindade, et al.
Clinical Genitourinary Cancer|October 20, 2022
"Non-metastatic, Castration-resistant Prostate Cancer: Diagnostic and Treatment Recommendations by an Expert Panel from Brazil"Denis L Jardim, Adriano Gonçalves E Silva, Alexandre Saad Fere Lima Pompeo, et al.
Cancer Immunology, Immunotherapy : CII|April 18, 2024
Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 studyFrancesco Massari, Matteo Santoni, Hideki Takeshita, et al.
Cancer Immunology, Immunotherapy : CII|September 7, 2023
Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective studyOndřej Fiala, Sebastiano Buti, Hideki Takeshita, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Journal of Cancer Research and Clinical Oncology|May 16, 2020
Advanced renal cell carcinoma (RCC) management: an expert panel recommendation from the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG)Andrey Soares, Fernando Sabino Marques Monteiro, Fernando Cotait Maluf, et al.
Therapeutic Advances in Urology|September 17, 2019
Renal cell cancer treatment: an expert panel recommendation from the Latin American cooperative group-genitourinary and the Latin American renal cancer group: focus on surgeryStênio de Cássio Zequi, Walter Henriques da Costa, Fernando Korkes, et al.
Clinical Genitourinary Cancer|August 24, 2024
The Impact of Fibroblast Growth Factor Receptor Alterations in Clinical Outcomes of Patients With Advanced Urothelial Carcinoma: Real-World Data From a Latin American PopulationVinicius Carrera Souza, Fernando Sabino Marques Monteiro, Fernando Cotait Maluf, et al.
Medrxiv : the Preprint Server for Health Sciences|August 20, 2025
Modelling Acral Melanoma in Admixed Brazilians Uncovers Genomic Drivers and Targetable PathwaysAnnie Cristhine Moraes Sousa-Squiavinato, Sara Santos Bernardes, Flávia C Aguiar, et al.
Lung Cancer Management|June 6, 2025
Lung cancer screening in limited resource regions: the 3rd Brazilian Early Lung Cancer Trial (BRELT3/mobile ProPulmão)Ricardo Sales Dos Santos, Ricardo G Figueiredo, Juliana P Franceschini, et al.
Journal of Cancer Research and Clinical Oncology|April 9, 2024
Advanced renal cell carcinoma management: the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG) consensus updateAndrey Soares, Fernando Sabino Marques Monteiro, Karine Martins da Trindade, et al.
Clinical Genitourinary Cancer|October 20, 2022
"Non-metastatic, Castration-resistant Prostate Cancer: Diagnostic and Treatment Recommendations by an Expert Panel from Brazil"Denis L Jardim, Adriano Gonçalves E Silva, Alexandre Saad Fere Lima Pompeo, et al.
Cancer Immunology, Immunotherapy : CII|April 18, 2024
Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 studyFrancesco Massari, Matteo Santoni, Hideki Takeshita, et al.
Cancer Immunology, Immunotherapy : CII|September 7, 2023
Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective studyOndřej Fiala, Sebastiano Buti, Hideki Takeshita, et al.
Pageof 6